AKT1 and malignant colon neoplasm: These observations from colorectal cancer patients provided support for the findings from cell and animal models, suggesting that cNrf2-induced PSMD4 may confer 5-FU resistance in colon cancer cells via the NF-κB/AKT/β-catenin cascade.